We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$269M
2
SMCI icon
Super Micro Computer
SMCI
+$220M
3
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$68M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$61M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFRI icon
3851
Forafric Global
AFRI
$291M
$9.64K ﹤0.01%
850
-1,438
-63% -$16K
TELO icon
3852
Telomir Pharmaceuticals
TELO
$76.3M
$9.62K ﹤0.01%
1,498
+550
+58% +$2.68K
PATH icon
3853
UiPath
PATH
$8.64B
$9.61K ﹤0.01%
751
-57,719
-99% -$707K
GEOS icon
3854
Geospace Technologies
GEOS
$67.9M
$9.61K ﹤0.01%
929
-1,410
-60% -$13.5K
QQQI icon
3855
NEOS Nasdaq 100 High Income ETF
QQQI
$14.1B
$9.6K ﹤0.01%
+187
New +$9.46K
MBI icon
3856
MBIA
MBI
$254M
$9.58K ﹤0.01%
2,683
-3,204
-54% -$13.2K
KALV
3857
DELISTED
KalVista Pharmaceuticals
KALV
$9.55K ﹤0.01%
825
-2,866
-78% -$36K
ATS icon
3858
ATS Corp
ATS
$2B
$9.53K ﹤0.01%
328
-1,683
-84% -$48.7K
FPXI icon
3859
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$305M
$9.53K ﹤0.01%
197
-19
-9% -$898
AVXL icon
3860
Anavex Life Sciences
AVXL
$316M
$9.51K ﹤0.01%
1,675
-21,996
-93% -$127K
LRMR icon
3861
Larimar Therapeutics
LRMR
$454M
$9.51K ﹤0.01%
1,452
-2,185
-60% -$17.6K
NRDY icon
3862
Nerdy
NRDY
$93.7M
$9.5K ﹤0.01%
9,667
-10,197
-51% -$13.1K
CRMD icon
3863
CorMedix
CRMD
$639M
$9.48K ﹤0.01%
1,173
-7,252
-86% -$39.2K
NOTE
3864
DELISTED
FiscalNote
NOTE
$9.48K ﹤0.01%
617
-807
-57% -$14K
DEM icon
3865
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$9.46K ﹤0.01%
215
-5
-2% -$217
VSTA
3866
DELISTED
Vasta Platform
VSTA
$9.46K ﹤0.01%
+3,596
New +$10K
JRVR icon
3867
James River Group Holdings
JRVR
$199M
$9.45K ﹤0.01%
1,507
-4,544
-75% -$33.4K
INZY
3868
DELISTED
Inozyme Pharma
INZY
$9.42K ﹤0.01%
1,802
-4,717
-72% -$24.5K
THRD
3869
DELISTED
Third Harmonic Bio
THRD
$9.42K ﹤0.01%
695
-2,817
-80% -$34.9K
TCI icon
3870
Transcontinental Realty Investors
TCI
$318M
$9.41K ﹤0.01%
327
-587
-64% -$17.2K
GEL icon
3871
Genesis Energy
GEL
$1.94B
$9.4K ﹤0.01%
703
+691
+5,758% +$9.41K
ALMS
3872
Alumis Inc
ALMS
$3.26B
$9.39K ﹤0.01%
+879
New +$10.7K
LXRX icon
3873
Lexicon Pharmaceuticals
LXRX
$1.04B
$9.37K ﹤0.01%
5,971
-10,981
-65% -$19.6K
ISD
3874
PGIM High Yield Bond Fund
ISD
$419M
$9.37K ﹤0.01%
+672
New +$9.11K
INNV icon
3875
InnovAge Holding
INNV
$1.42B
$9.37K ﹤0.01%
1,561
-5,547
-78% -$33K
153 154
155
156 157

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.